Steatohepatitis

Tumor Necrosis Factor Highly Expressed In Nonalcoholic Steatohepatitis

Published in Gene Therapy Weekly, January 24th, 2002

by Sonia Nichols, senior medical writer - The gene for an important cytokine is highly expressed in the tissues of patients with nonalcoholic steatohepatitis (NASH), suggesting the possibility of using targeted gene therapies for treating affected individuals.

NASH, also called nonalcoholic fatty liver disease, is a disease of the obese or diabetic, and can produce liver damage similar to that observed in people who consume too much alcohol. Liver fibrosis and liver cirrhosis sometimes becomes apparent in some but not all patients with NASH.

Researchers at the University Hospital of Marques de Valdecilla in Spain have compared adipose and liver...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2002-01-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry